Serum vascular adhesion protein-1 predicts all-cause mortality and cancer-related mortality in subjects with colorectal cancer

Li, Yu-IYu-ILiJI-SHIANG HUNGYu, Tse-YaTse-YaYuJYH-MING LIOUWei, Jung-NanJung-NanWeiHSIEN-LI KAOLEE-MING CHUANGCHIA-TUNG SHUNPO-HUANG LEEHONG-SHIEE LAISu, Chien-YinChien-YinSuHUNG-YUAN LIJIN-TUNG LIANG2023-02-082023-02-082014-01-200009-8981https://scholars.lib.ntu.edu.tw/handle/123456789/627752Vascular adhesion protein-1 (VAP-1) participates in inflammation and catalyzes the breakdown of amines to produce aldehyde, hydrogen peroxide, and ammonia. Serum VAP-1 can predict cancer mortality, including colorectal cancer (CRC) mortality, in type 2 diabetic subjects. However, it remains unknown if serum VAP-1 can predict mortality in CRC patients. This prospective cohort study investigates if serum VAP-1 is a novel biomarker for mortality prediction in CRC.enColorectal cancer; Mortality; Primary amine oxidase; Semicarbazide-sensitive amine oxidase; Vascular adhesion protein-1Serum vascular adhesion protein-1 predicts all-cause mortality and cancer-related mortality in subjects with colorectal cancerjournal article10.1016/j.cca.2013.10.024242117272-s2.0-84888080774WOS:000331682800009https://api.elsevier.com/content/abstract/scopus_id/84888080774